• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.

作者信息

Bloomfield Marketa, Parackova Zuzana, Hanzlikova Jana, Lastovicka Jan, Sediva Anna

机构信息

Department of Immunology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital in Motol, V Uvalu 84, Prague, 15006, Czech Republic.

Department of Pediatrics, 1st Faculty of Medicine, Charles University in Prague and Thomayer University Hospital, Prague, Czech Republic.

出版信息

J Clin Immunol. 2022 Feb;42(2):266-269. doi: 10.1007/s10875-021-01163-8. Epub 2021 Oct 31.

DOI:10.1007/s10875-021-01163-8
PMID:34718945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8557105/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d0/8557105/57df83a97dbd/10875_2021_1163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d0/8557105/57df83a97dbd/10875_2021_1163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33d0/8557105/57df83a97dbd/10875_2021_1163_Fig1_HTML.jpg

相似文献

1
Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.新冠病毒mRNA疫苗在信号转导和转录激活因子1功能获得性患者中的免疫原性和安全性
J Clin Immunol. 2022 Feb;42(2):266-269. doi: 10.1007/s10875-021-01163-8. Epub 2021 Oct 31.
2
Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.新冠病毒信使核糖核酸疫苗在使用肿瘤坏死因子抑制剂治疗的青少年特发性关节炎青少年中的免疫原性。
Ann Rheum Dis. 2022 Apr;81(4):592-593. doi: 10.1136/annrheumdis-2021-221607. Epub 2021 Nov 29.
3
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.优化非修饰 mRNA COVID-19 疫苗的非编码区。
Nature. 2022 Jan;601(7893):410-414. doi: 10.1038/s41586-021-04231-6. Epub 2021 Nov 18.
4
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.不同免疫细胞的动态变化与 SARS-CoV-2 mRNA 疫苗的免疫原性和反应原性相关。
Cell Rep Med. 2022 May 17;3(5):100631. doi: 10.1016/j.xcrm.2022.100631. Epub 2022 Apr 22.
5
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
6
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.实体器官移植受者完成mRNA SARS-CoV-2疫苗接种后体液免疫反应不佳。
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
7
Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2.HC009 mRNA 疫苗对 SARS-CoV-2 的免疫原性和保护效力。
Front Immunol. 2024 Jul 26;15:1416375. doi: 10.3389/fimmu.2024.1416375. eCollection 2024.
8
SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.SARS-CoV-2 mRNA 疫苗使抗病毒免疫与体液自身免疫脱钩。
Nat Commun. 2023 Mar 9;14(1):1299. doi: 10.1038/s41467-023-36686-8.
9
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.严重急性呼吸综合征冠状病毒2型信使核糖核酸疫苗在曾感染2019冠状病毒病的实体器官移植受者中的免疫原性
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
10
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.CD19+IgD+CD27- 幼稚 B 细胞可预测免疫功能低下患者对 COVID-19 mRNA 疫苗接种的体液免疫反应。
Front Immunol. 2021 Dec 7;12:803742. doi: 10.3389/fimmu.2021.803742. eCollection 2021.

引用本文的文献

1
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity.提高免疫缺陷患者中针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）特异性免疫的策略概述
Vaccines (Basel). 2024 Jun 18;12(6):675. doi: 10.3390/vaccines12060675.
2
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity.严重急性呼吸综合征冠状病毒 2 感染和 COVID-19 对先天性免疫缺陷病患者的影响。
J Allergy Clin Immunol. 2023 Apr;151(4):818-831. doi: 10.1016/j.jaci.2022.11.010. Epub 2022 Dec 13.
3
Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma.

本文引用的文献

1
COVID-19 in Patients with Primary Immunodeficiency.原发性免疫缺陷患者的新冠病毒病
J Clin Immunol. 2021 Oct;41(7):1515-1522. doi: 10.1007/s10875-021-01065-9. Epub 2021 Jul 6.
2
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.辉瑞-BioNTech COVID-19 疫苗在先天性免疫缺陷患者中的免疫原性。
J Allergy Clin Immunol. 2021 Sep;148(3):739-749. doi: 10.1016/j.jaci.2021.05.029. Epub 2021 Jun 1.
3
COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?
生物信息学和系统生物学分析确定 2019 年冠状病毒病对过敏性哮喘患者的影响。
Front Immunol. 2022 Sep 23;13:988479. doi: 10.3389/fimmu.2022.988479. eCollection 2022.
4
COVID-19 and Inborn Errors of Immunity.COVID-19 与先天性免疫缺陷
Physiology (Bethesda). 2022 Nov 1;37(6):0. doi: 10.1152/physiol.00016.2022. Epub 2022 Aug 9.
《COVID-19治疗指南：它们真的反映了应对这一流行病的最佳医疗实践吗？》
Infect Dis Rep. 2021 Apr 1;13(2):259-284. doi: 10.3390/idr13020029.
4
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.先天性免疫缺陷患者的 2019 年冠状病毒病：一项国际研究。
J Allergy Clin Immunol. 2021 Feb;147(2):520-531. doi: 10.1016/j.jaci.2020.09.010. Epub 2020 Sep 24.
5
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.回顾性多中心队列研究表明，早期干扰素治疗与 COVID-19 患者的良好临床反应相关。
Cell Host Microbe. 2020 Sep 9;28(3):455-464.e2. doi: 10.1016/j.chom.2020.07.005. Epub 2020 Jul 18.
6
mRNA vaccines - a new era in vaccinology.mRNA 疫苗——疫苗学的新纪元。
Nat Rev Drug Discov. 2018 Apr;17(4):261-279. doi: 10.1038/nrd.2017.243. Epub 2018 Jan 12.
7
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.杂合性信号转导和转录激活因子1（STAT1）功能获得性突变是一种临床表型出人意料广泛的疾病的基础。
Blood. 2016 Jun 23;127(25):3154-64. doi: 10.1182/blood-2015-11-679902. Epub 2016 Apr 25.
8
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).功能获得性 STAT1 突变会损害慢性黏膜皮肤念珠菌病（CMC）患者的 STAT3 活性。
Eur J Immunol. 2015 Oct;45(10):2834-46. doi: 10.1002/eji.201445344. Epub 2015 Sep 1.